Data / Form D filings / IRR, Inc.
IRR, Inc.: Form D filings
IRR, Inc., a pharmaceuticals company in Santa Barbara, CA, filed 6 Form D notices with the SEC between 2012 and 2018. The latest, on December 18, 2018, reports $150,000 sold of a $2 million offering to 1 investor.
Find out what IRR, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 515 EAST MICHELTORENA STREET, SUITE G, Santa Barbara, CA, 93103
- Phone
- (805) 681-1522
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 504
- SEC identifier (CIK)
- 1539828
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 18, 2018 | New notice | $2,000,000 | $150,000 | $1,850,000 | 1 | Dec 6, 2018 | sec.gov |
| Nov 24, 2017 | New notice | $1,000,000 | $980,000 | $20,000 | 2 | Nov 9, 2017 | sec.gov |
| Oct 5, 2016 | New notice | $10,000,000 | $15,000 | $9,985,000 | 1 | Sep 30, 2016 | sec.gov |
| Jul 7, 2015 | New notice | $250,000 | $0 | $250,000 | 0 | Yet to occur | sec.gov |
| Dec 3, 2014 | Amendment | $1,000,000 | $860,000 | $140,000 | 21 | Jun 18, 2012 | sec.gov |
| Jan 19, 2012 | New notice | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| LORIEL CHANDLER MAY | Executive Officer, Director | |
| B. CHANDLER MAY | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 17, 2018 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what IRR, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.